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OBJECTIVEdTo evaluate the feasibility of free-living walking training in type 2 diabetic
patients and to investigate the effects of interval-walking training versus continuous-walking
training upon physical ﬁtness, body composition, and glycemic control.
RESEARCHDESIGNANDMETHODSdSubjects with type 2 diabetes were randomized
to a control (n = 8), continuous-walking (n = 12), or interval-walking group (n = 12). Training
groups were prescribed ﬁve sessions per week (60 min/session) and were controlled with an
accelerometer and a heart-rate monitor. Continuous walkers performed all training at moderate
intensity, whereas interval walkers alternated 3-min repetitions at low and high intensity. Before
and after the 4-month intervention, the following variables were measured: VO2max, body
composition, and glycemic control (fasting glucose, HbA1c, oral glucose tolerance test, and
continuous glucose monitoring [CGM]).
RESULTSdTraining adherence was high (89 6 4%), and training energy expenditure and
mean intensity were comparable. VO2max increased 16.16 3.7% in the interval-walking group
(P, 0.05), whereas no changes were observed in the continuous-walking or control group. Body
mass and adiposity (fat mass and visceral fat) decreased in the interval-walking group only (P,
0.05). Glycemic control (elevated mean CGM glucose levels and increased fasting insulin) wors-
ened in the control group (P, 0.05), whereas mean (P = 0.05) and maximum (P, 0.05) CGM
glucose levels decreased in the interval-walking group. The continuous walkers showed no
changes in glycemic control.
CONCLUSIONSdFree-living walking training is feasible in type 2 diabetic patients. Con-
tinuous walking offsets the deterioration in glycemia seen in the control group, and interval
walking is superior to energy expenditure–matched continuous walking for improving physical
ﬁtness, body composition, and glycemic control.
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The number of patients with type 2diabetes is rapidly increasing, withan estimated 439 million people di-
agnosed worldwide by 2030 (1). There
are many reasons for this, among which
increased life span, increased obesity, and
increased urbanization with reduced
physical activity levels are seen as key
components (1). Physical activity is a
ﬁrst-line treatment in type 2 diabetes,
and the effect of physical activity on gly-
cemic control and body composition is
well documented (2,3). Most physical ac-
tivity interventions have used supervised
training regimes. When considering the
high prevalence of type 2 diabetes, fully
supervised training programs are not fea-
sible for primary-care exercise implemen-
tation. A need for training methods that
can be implemented and sustained in a
free-living environment is evident.
Physical ﬁtness level and physical
inactivity are strong predictors for all-
cause mortality (4), also in subjects with
type 2 diabetes (5,6). A training program
should therefore increase physical ﬁtness
level and physical activity. High-intensity
training favors improvements in physical
ﬁtness level (7), but more intense training
programs are associated with decreased
training adherence (8), and the overall
impact of exercise intensity in type 2 di-
abetic patients is still unclear (2).
Walking is feasible for most individ-
uals, and walking training programs have
been evaluated extensively in type 2 di-
abetic patients (9–16). These studies in-
dicate that walking training can be
implemented in type 2 diabetic patients,
but only minor or no beneﬁcial effects
have been shown, potentially indicating
that the intensity of normal walking is in-
sufﬁcient. Recently, high-intensity inter-
val training protocols have been evaluated
in subjects with metabolic syndrome and
type 2 diabetes (17,18). These studies
have shown drastic improvements in gly-
cemic control and cardiovascular risk fac-
tors, and although the high exercise
intensity usedmay limit the feasibility un-
der free-living and nonsupervised condi-
tions, it highlights the potential of interval
training modalities in type 2 diabetic pa-
tients.
Interval-walking training (IWT) has
been developed as a novel free-living
training modality that improves physical
ﬁtness and cardiovascular risk factors in
older subjects (19,20). IWT is implemen-
ted using a triaxial accelerometer training
device (JD Mate; Kissei Comtec, Matsu-
moto, Japan) (21) and consists of re-
peated cycles of slow and fast walking.
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These cycles are controlled by the JD
Mate, which audibly signals to subjects.
IWT has been successfully implemented
and sustained in large populations, but it
has never been tested in a group with dis-
ease.
The aim of this study was therefore to
test the feasibility of free-living walking
training in patients with type 2 diabetes,
using a randomized, controlled design.
Furthermore, we compared the efﬁcacy of
IWT with energy expenditure–matched
continuous-walking training (CWT)
with regards to changes in ﬁtness level,
body composition, and glycemic control.
We hypothesized that walking training
could be successfully implemented and
that IWT would be superior to CWT
with regards to improvements in physical
ﬁtness and glycemic control, despite ex-





Subjects with type 2 diabetes (22) were
recruited by advertisements in news-
papers and by contacting local diabetes
patient organizations. All volunteers un-
derwent medical screening, including a
health status interview, physical exam,
blood chemistry analysis, and oral glu-
cose tolerance test (OGTT). Exclusion cri-
teria included the use of exogenous
insulin, weight instability (.2 kg/6
months), physical activity (.150 min/
week), and evidence of liver, renal, and
cardiopulmonary disease and diseases
contraindicating physical activity (23).
A priori power calculations indicated
that n = 12 in each training group would
be sufﬁcient to detect signiﬁcant changes
in glycemic control. Initially, n = 24 sub-
jects were included in the study and ran-
domized to three groups: control (CON;
n = 8), CWT (n = 8), and IWT (n = 8). Two
subjects dropped out (one CWT subject
due to a knee injury and one IWT subject
due to new-onset asthmatic symptoms).
Subjects in the CON group were offered
rerandomization into a training group af-
ter the CON period. Five subjects ac-
cepted, adding n = 3 to the CWT group
and n = 2 to the IWT group. To meet the
planned sample size, an additional ﬁve
subjects were included and randomized
to one of the training groups, adding n =
2 to the CWT group and n = 3 to the IWT
group. The ﬁnal study population con-
sisted of n = 27 subjects undergoing the
intervention, of whom n = 5 underwent
both CON and either CWT or IWT.
Therefore, n = 32 pre- and posttrials
were included for statistical analysis
(CON, n = 8; CWT, n = 12; IWT, n = 12).
Written informed consent was ob-
tained from all subjects. This study was
approved by the ethical committee of the
Capital Region of Denmark.
Interventions
All subjects received a JDMate, which was
worn as a pedometer throughout the
study. In addition to this, subjects ran-
domized to a training group used the JD
Mate’s training function, which, based on
triaxial accelerometry, estimates training
energy expenditure. Initially, training
subjects performed a graded walking
VO2 peak test, from which peak energy-
expenditure rate was obtained (19,20).
The test was repeated monthly to ensure
that relative workload was consistent
with changes in aerobic ﬁtness. Subjects
in the CWT group had the target energy-
expenditure rate set for 55% of the peak
energy-expenditure rate and were in-
structed to perform CWT above the tar-
get. Subjects in the IWT group had the
target energy-expenditure rate set for
70% of the peak energy-expenditure rate
and were instructed to perform IWT con-
sisting of cycles of 3 min of fast walking
(above the target) and 3min of slow walk-
ing (below the target) according to a pro-
tocol described earlier (19,20). The aim
was to match CWT and IWT by overall
energy expenditure and mean training in-
tensity. All training subjects were pre-
scribed ﬁve training sessions per week,
60min/session for 4months, and training
effort was monitored by data upload ev-
ery second week. At these sessions, feed-
back of the training achievements was
provided. Furthermore, all training ses-
sions were performed with a heart rate
monitor (Polar RS400, Polar, Kempele,
Finland) as an additional measurement
of training intensity. Subjects in the
CON group were instructed to continue
their habitual lifestyle for 4 months and
had their JD Mate pedometer data uploa-
ded monthly.
Investigations
Prior to pre- and postintervention tests,
subjects abstained from their antidiabetic,
antihypertensive, and lipid-lowering
drugs for 5 days.
On day 1, a triaxial accelerometer
(Actiheart; CamNtech, Cambridge, U.K.)
(24) was provided to the subjects for
continuous monitoring of basal physical
activity over the following 6 days. A Min-
nesota Leisure Time Physical Activity
Questionnaire was completed to assess
habitual activity habits over the previous
4 months (25). A diet record was started
and continued for the following 3 days.
A continuous glucose monitoring (CGM)
system (Guardian Real-Time; Medtronic,
Santa Rosa, CA) was installed by insertion
of a glucose sensor (Sof-Sensor; Medtronic)
in the abdominal subcutaneous tissue. The
CGM systemwas calibrated three times per
day using a point-of-care glucose monitor
(Contour Link; Bayer, Z€urich, Switzer-
land). CGM continued for the following
3 days, and data from 2 full days (days 2
and 3) were used for analyses.
On day 4, after an overnight fast
($8 h), an antecubital venous catheter
was placed, and baseline blood samples
were collected for determination of
plasma glucose, lipids, HbA1c, and serum
insulin. A 3-h, 75-g OGTT was then per-
formed with blood collection every 20
min. Blood was collected into tubes con-
taining the following coagulation inhibi-
tors: sodium ﬂuoride tubes for glucose
analyses, lithium-heparin tubes for cho-
lesterol and triglyceride analyses, EDTA
tubes for HbA1c analyses, and serum
tubes (no inhibitors) for insulin analyses.
Blood samples for plasma collection were
immediately placed on ice and subse-
quently centrifuged (2,000g, 15 min,
48C). Samples for serum collection were
left at room temperature for 30 min and
centrifuged. Samples were stored at
2808C until analysis.
On day 6 or 7, subjects came in for
measurement of anthropometrical vari-
ables (weight and hip and waist circum-
ference). Body composition was assessed
by dual-energy X-ray absorptiometry (Lu-
nar Prodigy Advance; GE Healthcare,
Madison, WI). After 10 min of supine
resting, blood pressure was measured.
Maximal oxygen consumption (VO2max)
was measured by indirect calorimetry
during an incremental exhaustive tread-
mill (Technogym Runrace, Gambettola,
Italy) walking test. The test consisted
of a 5-min warm-up (individually deter-
mined moderate walking pace, 0% in-
cline) followed by 2-min stages of
increasing inclines (2% per stage) at indi-
vidually determined brisk walking pace
until the following criteria were met: pla-
teauing of heart rate and VO2 with incre-
mental workloads, respiratory exchange
ratio .1.1, or volitional exhaustion.
VO2max is reported as the mean of the
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two highest consecutive measurements
(10 s per measurement). Finally, a mag-
netic resonance imaging (MRI) scan (Sie-
mens Magnetom, 3 tesla, Erlangen,
Germany) of the abdominal region was
performed. After a localization scan, a
transversal, multislice, T1-weighted scan
was executed with 0.5 cm between slices.
A repeated measure of all tests was
conducted 4 months later, after subjects
had completed their randomized inter-
vention. Posttraining CGM measure-
ments commenced 48–72 h after the
ﬁnal exercise bout, and fasting blood sam-
ples and OGTTs were performed 96–120
h after the last exercise bout.
Analyses
Diet records were analyzed using Dankost
Slank version 2.0 (Danish Catering Cen-
tre, Herlev, Denmark).
Plasma glucose, cholesterol fractions,
and triglycerides were determined by an
enzymatic colorimetric assay (P-Modular;
Roche, Stockholm, Switzerland), HbA1c
by high-performance liquid chromatogra-
phy (Tosoh G7 Analyzer, San Francisco,
CA), and serum insulin by electrochemi-
luminescence immunoassay (E-Modular;
Roche).
MRI scans were analyzed using
Mango version 2.5 (Research Imaging
Center, University of Texas Health Sci-
ence Center at San Antonio, San Antonio,
Texas). The abdominal region was de-
ﬁned as delimited of the diaphragm mus-
cle proximally and a horizontal level of
the upper part of the sacral bone distally.
After manual exclusion of subcutaneous
and large-vessel fat tissue, a semiauto-
matic segmentation that included the
remaining (visceral) fat tissue was per-
formed. Volume was calculated by voxel
summation. All analyses were performed
by the same blinded observer.
Statistical analyses
Results are reported as mean 6 SEM.
Baseline differences were compared using
Fischer exact test for nonparametric var-
iables (sex and medication) and one-way
ANOVA for parametric variables. Since
baseline systolic blood pressure differed
between CWT and IWT, systolic blood
pressure was used as a covariate in
ANOVA analyses. Furthermore, other
potentially confounding variables (sex,
age, time since diagnosis, and baseline
HbA1c) were also used as covariates. Of
these baseline variables, only HbA1c was
related to intervention-induced changes
in our outcome variables of interest.
Two-way (group 3 time) repeated-
measures ANOVA was used to compare
pre- to postintervention changes within
and between groups. One-way (group)
ANOVA of D (post 2 preintervention)
values was used to compare intervention-
induced differences between groups. For
all ANOVAs, Bonferroni post hoc tests
were used to examine the difference
between means in the event of a signiﬁ-
cant ﬁnding. Training variables were
compared using unpaired, two-tailed
Student t test. Regression analyses were
performed using changes in relative
(mL/min/kg) and absolute (mL/min)
VO2max and body mass as independent
parameters. All analyses were repeated
excluding rerandomized subjects, which,
although resulting in underpowered
comparisons, did not change the pattern
of any results. Fischer exact test was per-
formed using SAS version 9.1 (SAS Insti-
tute, Cary, North Carolina). All other
analyses were performed using Prism ver-
sion 4 (GraphPad, San Diego, CA) or
SPSS version 20 (IBM, Armonk, NY). Sta-




Table 1 shows the baseline characteristics
of the subjects. Besides systolic blood
pressure, no baseline differences were
found between groups for any of the pa-
rameters listed in Table 1. No subjects
changedmedication during the study. Ta-
ble 1 also indicates intervention-induced
changes in variables of interest, including
intervention-induced differences be-
tween groups. Table 2 shows the energy
expenditure and dietary intake of subjects
prior to and during the intervention. No
differences were found within or between
groups regarding these parameters.
Training data
No differences in the steps per day were
found between the three groups on the
nontraining days. On training days, steps
per day were not different between CWT
and IWT, but both training groups
walked more daily steps than the CON
group when including both training and
nontraining days. Subjects in the CWT
and IWT groups trained for 59 6 2 min/
day on 4.5 6 0.1 days/week with a mean
adherence (volume of training performed
as compared with prescribed) of 896 4%.
No differences in mean adherence, mean
energy expenditure, or mean training
intensity (when comparing percentage of
maximum energy expenditure or percent-
age of maximum heart rate) were found
between CWT and IWT groups. Con-
versely, when comparing mean training
intensity of the IWT’s fast intervals with
mean CWT training intensity, a signiﬁcant
difference was found for the JD Mate–
measured intensity (P , 0.05) (Table 2).
VO2max
IWT subjects improved their relative
VO2max by 4.4 6 1.2 mL/kg/min
(16.1 6 3.7%, P , 0.001) and their ab-
solute VO2max by 249 6 85 mL/min
(10.9 6 3.2%, P , 0.01). No changes
were found in the CON or CWT groups
(Table 1 and Fig. 1A).
Body composition
Subjects in the IWT group lost 4.3 6 1.2
kg of bodyweight (P, 0.001) (Table 1 and
Fig. 1B). No signiﬁcant change in lean body
mass was observed, whereas body fat mass
decreased by 3.1 6 0.7 kg (P , 0.001)
(Table 1 and Fig. 1C). The fat mass lost
was accompanied by a decrease in the
waist-to-hip ratio (P, 0.01) (Table 1). Ad-
ditionally, abdominal visceral fat was de-
creased in the IWT group (0.54 6 0.15 L,
P , 0.001) (Table 1 and Fig. 1D). No
changes in any body compositional param-
eters were found in the CON or CWT
groups (Table 1 and Fig. 1B–D).
Lipids
Adecrease in LDL cholesterol of 0.46 0.2
mmol/L was found in the IWT group (P,
0.05) (Table 1). Total cholesterol in-
creased 0.5 6 0.2 mmol/L in the CON
group (P , 0.05) (Table 1). No changes
were found for HDL cholesterol or trigly-
cerides in any of the groups (Table 1).
Blood pressure
No changes were found in systolic or
diastolic blood pressure in any of the
groups (Table 1).
Glycemic control
HbA1c, fasting glucose, 2-h OGTT glucose,
maximum OGTT glucose, and area under
the OGTT glucose curve showed a trend to
increase in the CON group, while fasting
insulin signiﬁcantly increased (P , 0.05)
(Table 1). In the CON group, there was
also an increase in the mean (P , 0.05)
(Fig. 2A) and minimum (P , 0.05) (Fig.
2B) CGM glucose concentrations. Mean
(P = 0.05) (Fig. 2A) and maximum (P ,
0.01) (Fig. 2C) CGM glucose concentra-
tions decreased in the IWT group.
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CONCLUSIONSdThe main ﬁndings
of this study are that walking exercise
can be implemented as a free-living
training method in type 2 diabetic pa-
tients, and that IWT is superior to energy
expenditure–matched CWT with re-
gards to improvements in physical ﬁt-
ness, body composition, and glycemic
control, under the conditions used in
the current study. Our study design in-
cluded careful and successful matching
of the training energy expenditure and
mean intensity of the training groups,
despite the free-living nature of the in-
tervention. This justiﬁes comparisons
between IWT and CWT.
Despite the free-living nature and the
large amount of intended training in the
intervention (5 h/week), we experienced
high adherence and low dropout rates.
Other studies investigating walking train-
ing programs in type 2 diabetic patients
have, in general, reported lower adher-
ence rates (;60%) to the training
(9,11,13,14). Morikawa et al. (20) previ-
ously described excellent adherence to
IWT in a very large population. They spec-
ulated that the individualization of training
intensity and the regular feedback and in-
structions given to subjects played a role in
the high adherence (20). Furthermore, the
use of a device (the JD Mate) has proven
important for maintaining adherence to
training interventions (15).
As hypothesized, we found a differ-
ence in the physical ﬁtness level changes
Table 1dBaseline characteristics and changes in VO2max, body composition, lipids, blood pressure, and glycemic control
Control group Continuous-walking group Interval-walking group
Pre Post Pre Post Pre Post
n 8 12 12
Sex (male/female) 5/3 8/4 7/5
Medication
Diet only 5 4 4
Metformin 3 7 7
Sulfonylureas 1 3 3
DPP-4 inhibitors 1 0 1
GLP-1 analogs 1 1 1
Age (years) 57.1 6 3.0 60.8 6 2.2 57.5 6 2.4
Time since diagnosis (years) 4.5 6 1.5 6.2 6 1.5 3.5 6 0.7
VO2max
Relative (mL/kg/min)x 24.8 6 1.8 25.2 6 2.0 26.1 6 1.4 26.8 6 1.9 27.1 6 1.5 31.5 6 2.2***#‡
Absolute (mL/min)x 2,197 6 189 2,228 6 181 2,271 6 118 2,281 6 126 2,275 6 156 2,524 6 204**
Body composition
Body mass (kg)x 88.5 6 4.7 89.2 6 5.2 88.2 6 4.7 87.5 6 4.8 84.9 6 4.9 80.7 6 4.1***##‡
BMI (kg/m2)x 29.7 6 1.9 29.8 6 1.9 29.9 6 1.6 29.6 6 1.6 29.0 6 1.3 27.6 6 1.1***#‡
Lean body mass (kg) 58.8 6 4.6 58.8 6 4.8 59.9 6 3.2 59.2 6 3.2 56.1 6 3.7 55.0 6 3.3
Waist-to-hip ratio (%) 94.1 6 3.2 95.6 6 3.4 99.1 6 2.3 98.0 6 2.4 95.7 6 2.1 93.2 6 2.1**##
Fat mass (kg)x 28.2 6 3.2 28.7 6 2.9 28.3 6 3.1 28.2 6 3.2 28.8 6 2.7 25.7 6 2.7***##‡‡
Visceral fat (L)x 4.7 6 0.4 4.6 6 0.4 4.5 6 0.3 4.2 6 0.4 4.7 6 0.8 4.2 6 0.7***
Lipids
Total cholesterol (mmol/L)x 5.4 6 0.2 5.9 6 0.4* 5.3 6 0.3 5.5 6 0.3 5.0 6 0.3 4.9 6 0.2#
HDL cholesterol (mmol/L) 1.4 6 0.1 1.4 6 0.2 1.4 6 0.1 1.4 6 0.1 1.1 6 0.1 1.1 6 0.1
LDL cholesterol (mmol/L) 3.4 6 0.1 3.7 6 0.3 3.3 6 0.2 3.4 6 0.1 3.2 6 0.2 2.8 6 0.2*#
Triglycerides (mmol/L) 1.6 6 0.2 1.9 6 0.3 1.3 6 0.2 1.5 6 0.3 3.0 6 1.4 2.5 6 0.8
Blood pressure
Systolic (mmHg) 142 6 4.3 141 6 3.3 155 6 5.4 156.5 6 7.0 138 6 3.3† 137.8 6 3.6
Diastolic (mmHg) 86.6 6 3.5 88.6 6 2.8 90.0 6 1.8 89.6 6 2.7 85.0 6 2.8 84.9 6 2.7
Glycemic control
HbA1c (%) 6.4 6 0.2 6.8 6 0.3 6.6 6 0.2 6.6 6 0.3 6.9 6 0.2 6.8 6 0.3
Fasting glucose (mmol/L) 7.3 6 0.8 8.2 6 0.9 7.4 6 0.4 7.7 6 0.7 8.5 6 0.8 8.4 6 1.0
Fasting insulin (pmol/L) 82.1 6 10.7 118.0 6 15.7* 88.3 6 11.2 91.0 6 12.8 91.8 6 14.2 73.9 6 9.7##
2-h OGTT glucose (mmol/L) 14.7 6 1.4 15.7 6 1.4 14.8 6 1.0 15.0 6 1.4 16.5 6 0.9 15.4 6 1.3
Maximum OGTT glucose (mmol/L) 16.1 6 1.6 16.9 6 1.5 16.6 6 0.9 17.4 6 1.2 18.1 6 1.2 17.2 6 1.4
AUC OGTT glucose (mmol/L z min) 2,377 6 244 2,509 6 257 2,404 6 156 2,454 6 207 2,648 6 176 2,526 6 224
CGM glucose concentration
Mean (mmol/L) 7.1 6 1.0 8.3 6 1.1* 8.0 6 0.6 8.1 6 0.8 8.2 6 0.4 7.5 6 0.4{##
Minimum (mmol/L) 4.1 6 0.6 5.7 6 0.9* 5.2 6 0.3 5.1 6 0.6 4.6 6 0.4 4.7 6 0.4
Maximum (mmol/L) 11.4 6 1.6 12.8 6 1.8 13.3 6 1.2 13.0 6 1.2 13.8 6 1.0 11.1 6 0.5**##
AUC, area under the curve; DPP-4, dipeptidyl peptidase-4; GLP-1, glucagon-like peptide-1. xMain effect of time. #P, 0.05,DIWT vs.DCON. ##P, 0.01,DIWT vs.
DCON. ‡P, 0.05,DIWT vs.DCWT. ‡‡P, 0.01,DIWT vs.DCWT. †P, 0.05, Pre-IWT vs. Pre-CWT. {P = 0.05, within group Pre vs. Post. *P, 0.05, within group
Pre vs. Post. **P , 0.01, within group Pre vs. Post. ***P , 0.001, within group Pre vs. Post.
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between the training groups, with an
increase in VO2max in the IWT group
and no increase in the CWT group. Fur-
thermore, subjects in the CWT group did
not show any signiﬁcant improvements in
body composition or glycemic control.
Type 2 diabetic patients’ self-paced walk-
ing speed is low, and potentially too low
to improve health-related outcome
(16,26), and previous studies using
CWT interventions report only modest
improvements in health-related parame-
ters (9–11,13,15). Thus, it is likely that
walking speed in our CWT group was
close to the subjects’ normal walking
speed, possibly explaining the apparent
lack of effect.
Since overall energy expenditure was
matched between the training groups,
and no evidence of different dietary intake
within or between any of the groups was
found, we expected that body composi-
tion would change equally (27,28). We
found that IWT led to a greater reduction
in body weight, fat mass, and abdominal
visceral adiposity than CWT. Irving et al.
(29) described similar ﬁndings, with a
greater loss of fat mass, including visceral
fat mass, after higher-intensity training.
Our results indicate that ﬂuctuations in
training intensity may have greater inﬂu-
ence on body composition than average
training intensity. Postexercise O2 con-
sumption has been shown to correlate ex-
ponentially with training intensity (30).
Although there are no published studies
examining this concept in our study de-
sign, we speculate that postexercise O2
consumption was greater in the IWT
group, leading to a greater overall energy
expenditure during the intervention and
thereby inducing greater weight loss than
CWT. Further studies, where food intake
is strictly controlled and standardized, are
necessary to prove this speculation.
Over the 4-month period, the glycemic
control of CON group subjects deterio-
rated. This deterioration was prevented in
subjects who undertook CWT. Subjects
who undertook IWT showed signiﬁcant
improvements in some parameters of gly-
cemic control (Table 1 and Fig. 2). The fact
that IWT reduced hyperglycemic episodes
without leading to hypoglycemic episodes
is also a very important ﬁnding. Glycemic
excursions cause oxidative stress and car-
diovascular complications in subjects with
type 2 diabetes (31), and glycemic spikes
are related to atherosclerosis in type 2 di-
abetic patients (32). Manders et al. (33)
Table 2dEnergy intake and expenditure and training data
Control group Continuous-walking group Interval-walking group
Pre During Pre During Pre During
Energy intake
Energy intake (kcal/day) 2,108 6 204 2,090 6 158 2,350 6 182 2,054 6 211 2,105 6 144 2,147 6 144
Protein (%) 20 6 1 17 6 1 17 6 1 19 6 1 20 6 2 18 6 1
Fat (%) 30 6 3 35 6 3 33 6 2 30 6 2 34 6 2 38 6 2
Carbohydrate (%) 50 6 3 48 6 3 50 6 2 51 6 2 46 6 2 44 6 2
Energy expenditure
MLTPAQ (kcal/day)† 225 6 78 156 6 47 214 6 54 160 6 35 289 6 82 179 6 36
Actiheart AEE (kcal/day) 743 6 171 741 6 177 569 6 93 570 6 96 687 6 180 568 6 183
Actiheart TEE (kcal/day) 2,715 6 166 2,730 6 190 2,482 6 121 2,476 6 121 2,585 6 202 2,402 6 213
Steps per day
Nontraining days 8,144 6 1,169 8,540 6 718 8,449 6 515
Training days d 13,305 6 761 12,608 6 905
Overall 8,144 6 1,169 11,780 6 693* 11,451 6 757#
Training amount
Training days per week 4.6 6 0.1 4.4 6 0.2
Training duration per session (min) 61 6 3 57 6 1
Overall adherence (%) 94 6 6 85 6 4
Training energy expenditure
Total (kcal) 28,092 6 3,207 28,948 6 2,971
Per session (kcal) 340 6 34 336 6 28
Per body mass per time (cal/kg/min) 63 6 4 69 6 4
Training intensity (energy expenditure)
Slow walking interval (%) d 53.9 6 1.8
Fast walking interval (%) d 89.4 6 2.0‡
Mean (%) 72.7 6 3.6 70.5 6 2.0
Training intensity (heart rate)
Slow walking interval (%) d 62.5 6 1.8
Fast walking interval (%) d 68.9 6 1.8
Mean (%) 66.4 6 1.4 65.7 6 1.7
Actiheart AEE, measured daily basal physical activity energy expenditure; actiheart TEE, measured daily total energy expenditure; MLTPAQ, Minnesota Leisure Time
Physical Activity Questionnaire (25) (reported daily leisure time physical activity energy-expenditure excluding training intervention energy expenditure); overall
adherence, fraction of training performed as compared with instructed; training intensity (energy expenditure), fraction of average training energy-expenditure rates
as compared with the mean peak energy-expenditure rate measured by the JDMate; training intensity (heart rate); fraction of average training heart rates as compared
with the maximum heart rate measured during VO2max tests. †Main effect of time. *P, 0.05, CWT vs. CON. #P, 0.05, IWT vs. CON. ‡P, 0.05, IWT fast walking
interval vs. CWT overall.
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showed that a single low-intensity exercise
bout was able to reduce free-living hyper-
glycemic episodes measured by CGM the
24 h after the exercise, but to our knowl-
edge, no studies have previously described
a long-term exercise intervention’s ability
to reduce free-living hyperglycemia. Re-
cently, however, Mikus et al. (34) showed
that 7 days of aerobic exercise with strict
dietary control reduces postprandial glu-
cose and glycemic variability in patients
with type 2 diabetes. Our results are in
line with these previous ﬁndings, and ex-
tend them to a longer-term training inter-
vention with free-living dietary intake.
Whether or not this reduction in hypergly-
cemic episodes after training improves car-
diovascular outcome in subjects with type
2 diabetes is unknown.
We did not ﬁnd signiﬁcant changes in
most of the “classical” glycemic control
variables (e.g., fasting glucose and
HbA1c), whereas signiﬁcant changes in
CGM were apparent. This divergence
may be explained by several points. First,
fasting glucose is primarily dependent on
endogenous glucose production (35).
Whether or not endogenous glucose pro-
duction is altered in response to training
is controversial (36,37), but at least fast-
ing glucose seems unaffected by training
(38). Second, we experienced large vari-
ability in HbA1c changes in the IWT
group (mean D values 6 SEM, 20.09 6
0.17%). If a single subject with rapidly
progressing (3 years since diagnosis), severe
disease (fasting glucose = 16.3 mmol/L;
HbA1c = 8.2%), who experienced serious
deterioration in classical glycemic control
variables after the training intervention
(fasting glucose = 18.3 mmol/L; HbA1c =
9.8%), was removed from the statistical
analysis, signiﬁcant improvements in
HbA1c were encountered in the IWT
group (DHbA1c = 20.25 6 0.08%, P ,
0.05). This may indicate a potential inter-
action between the stage of disease and the
response to exercise training. Indeed, Dela
et al. (39) previously showed that type 2
diabetic patients with poor glycemic con-
trol had poor responsiveness to exercise
training. In support of this, regression
analyses of our data indicate that in type
2 diabetic patients, a higher baseline
HbA1c is associated with a smaller train-
ing-induced reduction in HbA1c (baseline
HbA1c vs. DHbA1c in training groups; r =
0.54, P, 0.01), evidence that exercise re-
sponsiveness may be inﬂuenced by the
underlying state of glycemic control.
Even though divergence between
changes in OGTT- and CGM-derived
Figure 1dSubjects with type 2 diabetes were randomized to a CON (white bars), CWT (striated
bars), or IWT group (black bars). Aerobic ﬁtness (VO2max) (A), body mass (B), whole-body fat
mass (dual-energy X-ray absorptiometry) (C), and abdominal visceral adiposity (MRI) (D) were
measured at baseline and after 4 months. Data are presented as mean D values (post 2 pre-
intervention values)6 SEM. Statistical differences were analyzed by two-way repeated-measures
ANOVA when comparing pre to post changes within groups (indicated by ***P , 0.001), and
one-way ANOVA of D values when comparing differences between groups (indicated by a con-
necting line between bars; *P , 0.05 and **P , 0.01).
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parameters has recently been described
(34), we did expect that changes in 2-h
and maximum OGTT glucose would be
in line with changes in mean CGM glu-
cose. As a result, we were surprised that
these OGTT-derived parameters did not
improve in the IWT group, especially
when considering the drop in maximum
CGM glucose values after the interven-
tion. A possible explanation for this dis-
crepancy would be that dietary intake
changed pre to post in the IWT group,
which, however, was not the case (Table
2). Another explanation could be that the
time between the last training session and
blood sampling was longer than the du-
ration over which improved glycemic
control after exercise persisted (40). The
last training day of the subjects was at
least 48 h before beginning the CGM
period and at least 96 h before the blood
sampling. Although this explanation
is speculative, it highlights the impor-
tance of regular physical activity upon
sustained improvements in glycemic
control.
A limitation of this study is that we
experienced a difference in body compo-
sitional changes between the training
groups. Therefore, we cannot conclude
whether the improved VO2max on its
own leads to better glycemic control in
the IWT group or if this is solely a result
of the improved body composition. Re-
gression analyses, where D values (post-
study2 prestudy) of either body mass or
relative VO2max (mL/kg/min) were used
as the independent variable, indicate that
changes in VO2max and body mass are
both correlated with changes in most of
the investigated parameters of glycemic
control (data not shown). When absolute
changes in VO2max (L/min) were used as
the independent variable, relationships
persisted between changes in VO2max
and changes in mean 48-h CGM glucose
(r =20.47, P, 0.05) andmaximum48-h
CGM glucose (r = 20.53, P , 0.01). Al-
though these are not causative relation-
ships, they indicate that improvements
in VO2max per se are related to changes
in glycemic control independent of
weight loss. In addition to this, the im-
provement in body composition seen in
the IWT group remains an important
clinical ﬁnding.
A further limitation of the study is
that postintervention parameters were
measured at least 48 h after and up to 8
days after the last training bout (day 7).
This duration indeed may result in de-
training effects. However, this would
Figure 2dSubjects with type 2 diabetes were randomized to a CON (white bars), CWT (striated
bars), or IWT group (black bars). Intervention-induced changes in glycemic control were as-
sessed by examining post2 preintervention changes in the following variables: mean 48-h CGM
glucose (A), minimum 48-h CGM glucose (B), and maximum 48-h CGM glucose (C). Data are
presented as mean D values (post2 preintervention values)6 SEM. Statistical differences were
analyzed by two-way repeated-measures ANOVA when comparing pre to post changes within
groups (indicated by *P , 0.05 and **P , 0.01), and one-way ANOVA of D values when
comparing differences between groups (indicated by a connecting line between bars; **P, 0.01).
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elicit equal underestimation of the bene-
ﬁcial effects in both training groups.
Furthermore, our design enables us to
evaluate the training-induced effects on
glycemic control, independent of the
acute effects of exercise.
In summary, we have shown that
free-living walking training can be imple-
mented in a population with type 2 di-
abetes. Furthermore, we have shown that
IWT and CWT counteract deteriorations
in glycemic control and that IWT is
superior to CWT with regards to im-
provements in physical ﬁtness, body
composition, and glycemic control. IWT
may therefore be a good option when
considering which type of training type 2
diabetic patients should be offered in
primary care.
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